{
  "docId": "019de074-4550-75c8-b409-3e681fefedb4",
  "docSlug": "3148a2a91ddd74e886a30db191b6b33b",
  "documentTitle": "AbCellera | Results Presentation Deck | 23 slides",
  "authorId": "abcellera",
  "authorName": "AbCellera",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-02-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 5,
  "pageCount": 23,
  "prevPage": 4,
  "nextPage": 6,
  "slideType": "key_messages",
  "function": "summarize",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "The slide uses a dark, professional aesthetic with a background image of a scientist working on a glass board, reinforcing the 'target to clinic' theme.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de074-4550-75c8-b409-3e681fefedb4/5",
  "deckHref": "/decks/019de074-4550-75c8-b409-3e681fefedb4",
  "deckJsonHref": "/decks/019de074-4550-75c8-b409-3e681fefedb4.json",
  "deckAnchorHref": "/decks/019de074-4550-75c8-b409-3e681fefedb4#slide-5",
  "components": [
    {
      "bbox": {
        "h": 0.3,
        "w": 0.03,
        "x": 0.02,
        "y": 0.5
      },
      "kind": "other",
      "text": "FULL YEAR 2022 BUSINESS UPDATE",
      "attrs": null,
      "subkind": "unclassified",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8cae3398-2a25-4553-a2bf-73350c7f5429",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.6,
        "x": 0.157,
        "y": 0.687
      },
      "kind": "paragraph",
      "text": "Build a large and diversified portfolio of stakes in future antibody therapeutics.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "70044dde-abe6-46e8-a940-4e8160cfaa1c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.6,
        "x": 0.157,
        "y": 0.345
      },
      "kind": "paragraph",
      "text": "Be best in world in antibody therapeutics from target to the clinic.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f33ca046-b67d-48a8-9623-ad2180206088",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.025,
        "w": 0.12,
        "x": 0.157,
        "y": 0.625
      },
      "kind": "title",
      "text": "STRATEGY #2",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4efe4fd5-702b-4aab-90db-d0f3420f2e50",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.025,
        "w": 0.12,
        "x": 0.157,
        "y": 0.283
      },
      "kind": "title",
      "text": "STRATEGY #1",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fece9756-f6c9-48b6-b58a-f060d0db3b28",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 6,
      "from": 5,
      "beatId": "aed0ceee-0858-4462-9b90-613f96993ddb",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Solution",
      "beatSlug": "sequoia-pitch-solution",
      "evidence": "The document presents AbCellera's solution, including its antibody discovery engine and portfolio of stakes in future antibody therapies.",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [
    {
      "to": 6,
      "from": 3,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "5702edfd-b461-4ace-a3f1-79aaa73043cd",
      "evidence": "The document presents the need for antibody therapeutics and the potential consequences of not investing in this area.",
      "position": 0,
      "objective": "The cost of not investing in antibody therapeutics",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}